Latest filing published 17 Dec 2025 for Oric Pharmaceuticals, Inc.. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Pratik S. Multani is a declared insider at 3 companies (board member); the most frequent names are Oric Pharmaceuticals, Inc., Erasca, Inc. and Ignyta, Inc. The record holds 8 filings, for trades running from 7 January 2016 to 15 December 2025.
In open-market terms, that means 1 purchase worth €84k on one side and 1 sale worth €6,412 on the other. On balance, insiders were net buyers of €78k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant and 4 option exercises.
The newest entry dates from 17 December 2025: an option exercise, in Oric Pharmaceuticals, Inc. The most recent open-market purchase was published on 20 July 2021, 1,916 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations